Published in Blood Weekly, November 23rd, 1998
The 55-year-old woman was given the first dose of the drug, Combretastatin, by intravenous infusion on November 9, 1998, at the Ireland Cancer Center. She had been diagnosed in February 1998 with adenocarcinoma, a cancer with an unknown origin. Doctors found malignant tumors in her liver. She underwent two other forms of chemotherapy, which failed, before she volunteered for the Combretastatin study.
Scot C. Remick, MD, program...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Blood Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.